← Back to Search

Behavioral Intervention

Gentle Moves for Mild Cognitive Impairment and Dementia (Pro-Home MeC Trial)

Phase 1
Recruiting
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Pro-Home MeC Trial Summary

This trial will assess physical activity and cognitive outcomes for inactive older adults with MCI/mild dementia in a memory clinic.

Who is the study for?
This trial is for people aged 50 or older who speak English and have been diagnosed with mild cognitive impairment (MCI) or mild dementia. They should be physically inactive, doing less than 150 minutes of planned exercise per week, and able to sit independently for at least 15 minutes. Those with significant mental or physical disabilities, severe hearing or vision loss, insufficient decision-making capacity, lack of safety awareness, current participation in similar research, or unwillingness to be assigned randomly can't join.Check my eligibility
What is being tested?
The 'Pro-Home MeC' study tests a physical activity program called 'Gentle Moves' designed for older adults with MCI or mild dementia in a memory clinic setting. The goal is to see if the program is doable and liked by participants while also checking its effect on brain function.See study design
What are the potential side effects?
Since 'Gentle Moves' involves light physical activities tailored for older adults with cognitive impairments, side effects might include typical exercise-related issues such as muscle soreness or fatigue but are expected to be minimal given the gentle nature of the exercises.

Pro-Home MeC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of NIH Toolbox Cognition Battery
Program Acceptability
Program Feasibility
Secondary outcome measures
NIH Toolbox Cognition Battery scores

Pro-Home MeC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Gentle MovesExperimental Treatment1 Intervention
Three-month physical activity intervention.
Group II: Usual CareActive Control1 Intervention
Usual care provided by neuropsychologist.

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
609 Previous Clinical Trials
1,559,281 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,857 Total Patients Enrolled

Media Library

Gentle Moves (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Clinical Trial 2023: Gentle Moves Highlights & Side Effects. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Research Study Groups: Usual Care, Gentle Moves
Gentle Moves (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05771064 — Phase 1
Mild Cognitive Impairment Patient Testimony for trial: Trial Name: NCT05771064 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacant slots for participants in this examination?

"Per the information found on clinicaltrials.gov, this research project is presently recruiting participants. The trial was initially published on March 21st 2023, and underwent its latest amendment on March 29th of that same year."

Answered by AI

Has the FDA given its stamp of approval to Gentle Moves?

"Due to the lack of evidence for Gentle Moves' efficacy and safety, it has been graded a 1 on our team's scale from 1-3."

Answered by AI

To what degree has the capacity of this trial been met?

"Affirmative. According to the clinicaltrials.gov website, this medical trial is actively searching for 44 participants at 1 site and was made available on March 21st 2023 with its last update occurring 8 days later."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
What site did they apply to?
Naoko Muramatsu
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Alzheimer's runs through my family.
PatientReceived no prior treatments
Recent research and studies
clinicaltrials.govStudy
Promoting In-Home Activities at a Memory & Aging Clinic
Naoko Muramatsu 2023. "Promoting In-Home Activities at a Memory & Aging Clinic". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05771064.
~2 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top